Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-06-28
2005-06-28
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S228800, C514S237800, C514S331000, C514S646000, C544S063000, C544S162000, C546S231000, C564S225000, C564S238000, C564S244000, C564S305000
Reexamination Certificate
active
06911477
ABSTRACT:
This invention relates to a novel class of partial or full muscarinic receptor agonists intermediates for their preparation, and pharmaceutical compositions and methods of use for the treatment or prevention of diseases the treatment or prevention of which is mediated by muscarinic receptor agonism.
REFERENCES:
patent: 5294708 (1994-03-01), Breslin et al.
Wyngaarden et al. “Texbook of medicine” Sandouders p. 2031 (1983).
BakerBotts “In Print” Attorneys practice profile new and event (2002).
Levey “Muscarinic acetylcholine receptor . . . ” CA 126:29654 (1996).
Kan et al. “SR 46559 A . . . ” CA 119:262442 (1993).
Wilbraham et al. “Organic and biological chemistry” Ben/Cummings Pubs. p. 268-269 (1985).
Sills “In vitro screens and functional assays to assess receptor pharmacology” CA 121:148192 (1994).
Liston Dane R.
Nowakowski Jolanta
Villalobos Anabella
Yohannes Daniel
Chang Celia
Jubinsky James A.
Ling Lorraine B.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Muscarinic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3474064